J. Kanter

Acidity and tautomerism of .beta.-keto esters and amides in aqueous solution

J. W. Bunting, J. Kanter, 1993 .

Design, synthesis, and SAR of substituted acrylamides as factor Xa inhibitors.

J. Woolfrey, B. Zhu, Yonghong Song, 2002, Bioorganic & medicinal chemistry letters.

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor.

Lingyan Wang, Gary Park, James Kanter, 2009, Bioorganic & medicinal chemistry letters.

Design, synthesis, and SAR of substituted acrylamides as factor Xa inhibitors.

J. Woolfrey, B. Zhu, Yonghong Song, 2002, Bioorganic & Medicinal Chemistry Letters.

Kinetics and mechanism of the formation of N-vinyl pyridinium cations in elimination reactions in aqueous base

J. W. Bunting, J. Kanter, A. Toth, 1992 .

A change in the rate-determining step in the E1cB reactions of N-[2-(4-nitrophenyl)ethyl]pyridinium cations

J. W. Bunting, J. Kanter, 1991 .

The acidity and tautomerism of β-diketones in aqueous solution

J. W. Bunting, J. Kanter, Raymond Nelander, 1995 .

Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors.

J. Woolfrey, B. Zhu, C. Marlowe, 2001, Bioorganic & medicinal chemistry letters.